source
- States could counter potential Trump administration vaccine shortages by producing vaccines themselvesJoel Dodge, director of industrial policy at Vanderbilt Policy Accelerator, warns that the Trump administration is considering changes to the Vaccine Injury Compensation Program, a policy that has…
- OMass Therapeutics secures $310M Series C, eyes status as Britain’s leading biotechOMass Therapeutics, an Oxford‑based biotech still in pre‑clinical stage, announced a new financing round that brings in $310 million. The series C, co‑led by Bain Capital Life Sciences, Forbion an…